Guide — Reading an Absence
Three positions get reported as if they were one sentence: nobody looked, someone looked and found nothing, someone looked and found worse. Distinguishing them takes one question, and it changes what every claim in this aisle is worth.
Two Blanks
An old chart marked unsurveyed areas differently from surveyed ones. Both regions had no hazards drawn on them, and the difference between them was the difference between we looked and it is clear and nobody has been there. A navigator who confused the two was in serious trouble in one direction and needlessly cautious in the other.
Health claims arrive with the same two blanks and no notation to tell them apart. When you read that there is no evidence a compound helps, that sentence covers two completely different situations: nobody has run an adequate trial, or someone has and it did not work. Those are not degrees of the same finding.
What makes this worth a whole guide is that the confusion is exploited in both directions. A seller points at the first blank and calls it promise — the science is emerging, the trials are coming. A debunker points at the same blank and calls it settled — there is no evidence, therefore it does not work. Both have substituted an absence for a result, and both are wrong in the same way while arriving at opposite conclusions.
Telling them apart is a matter of asking what was actually done, and by whom.
Most compounds in this category sit here. The guide covers how to establish it — searching trial registries rather than product pages, and recognising when a citation list contains only laboratory or animal work.
What it does not license: optimism. Untested means the benefits are unknown and so are the harms. This is the position most often dressed up as promise, and it is the one that should make you slowest, not fastest.
Several of the best-known ingredients in the prostate aisle sit here, having been tested at proper scale by publicly funded trials. The guide names the distinction between a trial that found nothing and one too small to have found anything.
What it does license: a firm conclusion, within the limits of what was tested — that dose, that duration, that population. A null result at one dose is not a null result at every dose, and honest reporting says which.
These are the results that ended lines of inquiry, and they almost never appear in consumer material about the compounds concerned. The guide sets out the main examples and what each one changed.
Why it matters here: it demonstrates that the first position is not neutral. If untested compounds were harmless by default, a finding like this could not happen. It has happened, more than once.
Contents
Digital Guide · PDF Format
One distinction, applied to the whole aisle — and a method for placing any claim into the right one of three positions.
Tax included · Instant download · One-time payment
Read it at your own pace. If what arrives does not match what this page sets out, the full amount is returned within 14 days of purchase, by email, with no reason requested.
Notice: This is not a medical portal and provides no diagnostic or treatment service. What is sold here is education about how to read an absence of evidence. It names no brand and endorses no product. Nothing in it suggests that an untested compound is worth trying — untested means the risks are unmeasured as well as the benefits. Nor does it apply to advice a clinician has given you personally. If you have symptoms, pain, or any concern, book an appointment.
FDA Statement: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Intended for adults 18 years of age or older.
This site is not operated by or affiliated with Google. Google is a registered trademark of Alphabet Inc.